Latest News and Press Releases
Want to stay updated on the latest news?
-
RALEIGH, N.C., June 16, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that the Company's CEO, Ken Reali, will present at the JMP Securities Healthcare Conference in New...
-
– First quarter revenue was $4.4 million – – Net loss per share was $0.19 for the quarter – – Avance™ MIS Pedicle Screw System receives FDA clearance...
-
Baxano Surgical, Inc. Schedules First Quarter 2014 Results Conference Call for Thursday, May 8, 2014
RALEIGH, N.C., April 25, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release first quarter 2014 financial and operating results after market close on...
-
RALEIGH, N.C., April 23, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) ("Baxano Surgical" or the "Company"), a medical device company focused on designing, developing and marketing...
-
RALEIGH, N.C., April 10, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat...
-
RALEIGH, N.C., March 14, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat...
-
RALEIGH, N.C., March 11, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) ("Baxano Surgical" or the "Company"), a medical device company focused on designing, developing and marketing...
-
RALEIGH, N.C., March 7, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in the Canaccord Genuity Musculoskeletal Conference on March 11,...
-
– Fourth Quarter Revenue Was $6.0 Million – – iO-Flex Achieves 7% Sequential Growth, iO-Tome Launched – – Net Loss Per Share Was $0.19 for the Quarter...
-
RALEIGH, N.C., March 3, 2014 (GLOBE NEWSWIRE) -- Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release fourth quarter 2013 financial and operating results after market close on...